News Updates
More Articles
- Japan’s Third Health and Medical Strategy Adds Infectious Diseases and Clinical Trial Acceleration
- NICE Methods Changes: What, When, Why, and the Expected Impact on Patient Access to Medicines
- Regulatory Efficiency in the Philippines: Good Submission Practice and Good Review Practices
- The European Health Data Space (EHDS): Breakthrough Moment in Sharing Health Data: Are We Ready for Implementation?
- Invisible in Evidence: Where Regulation Still Falls Short for Women
NICE Methods Changes: What, When, Why, and the Expected Impact on Patient Access to Medicines
NICE Methods Changes: What, When, Why, and the Expected Impact on Patient Access to Medicines
NICE officially announced in December 2025 that its standard cost-effectiveness threshold will increase by 25% effective April 2026.
×
